Obinutuzumab in Refractory Membranous Nephropathy: A Case Series
Rationale & Objective: Membranous nephropathy (MN), recognized as an autoimmune kidney disease, responds well to anti-CD20 monoclonal antibodies. Obinutuzumab, a type Ⅱ humanized anti-CD20 and immunoglobulin G1 Fc-optimized monoclonal antibody, when compared with rituximab, has demonstrated supe...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2024-08-01
|
| Serie: | Kidney Medicine |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2590059524000645 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|